T. Rowe Price Health Care ETF Rating $31.72 0.00 (0.00%) As of 06/12/2026 01:06 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock T. Rowe Price Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMED Aggregate RatingModerate Buy 2.82Holdings in TMED have an aggregate rating of Moderate Buy based on 563 analyst ratings issued in the past year covering 25 companies (72.8% of the portfolio).TMED Aggregate Price Target$31.72High Prediction$31.72Average Prediction$31.72Low Prediction$31.72Holdings in TMED have an aggregate price target of $31.72 and a range of $31.72 to $31.72 covering 25 companies (72.8% of the portfolio).TMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by T. Rowe Price Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings17.74%LLYEli Lilly and Company$1,137.01+0.4%4.1028 of 5 stars2.87$1,227.74 8.0%30Trending NewsAnalyst RevisionGap Up7.85%UNHUnitedHealth Group$408.340.0%4.1992 of 5 stars2.78$407.17 -0.3%27Trending NewsOptions Volume4.26%TMOThermo Fisher Scientific$468.80-0.1%4.8983 of 5 stars2.88$608.95 29.9%25Positive NewsAnalyst Revision4.14%GILDGilead Sciences$125.594.9212 of 5 stars2.86$156.93 25.0%29Trending NewsAnalyst Revision3.54%ABTAbbott Laboratories$87.89-0.3%4.9853 of 5 stars2.88$118.38 34.7%26Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision3.17%DHRDanaher$179.95-0.1%4.715 of 5 stars2.84$233.61 29.8%25Trending News2.38%SYKStryker$312.140.0%4.9231 of 5 stars2.73$395.33 26.7%22Positive News2.27%BSXBoston Scientific$46.83-0.2%4.9552 of 5 stars2.80$85.08 81.7%30Trending NewsAnalyst ForecastShort Interest Increase2.12%ELANElanco Animal Health$24.19+0.1%3.5723 of 5 stars2.77$28.20 16.6%132.01%ALNYAlnylam Pharmaceuticals$282.854.6298 of 5 stars2.85$463.13 63.7%26Positive NewsAnalyst UpgradeGap Up1.94%AAgilent Technologies$129.76-0.1%4.9706 of 5 stars2.88$160.93 24.0%17Positive News1.85%PODDInsulet$149.704.6521 of 5 stars2.74$240.78 60.8%27Positive News1.83%CORCencora$281.560.0%4.8604 of 5 stars2.80$374.00 32.8%151.83%WATWaters$355.10-0.1%3.2223 of 5 stars2.71$394.56 11.1%21Positive News1.80%DXCMDexCom$75.374.4252 of 5 stars2.92$84.29 11.8%26Positive News1.68%DYNDyne Therapeutics$18.193.0638 of 5 stars2.94$35.00 92.4%17Positive News1.67%WSTWest Pharmaceutical Services$328.33-0.1%3.5536 of 5 stars3.00$340.09 3.6%14Positive News1.55%MCKMcKesson$783.880.0%4.9071 of 5 stars2.82$960.53 22.5%17Positive NewsShort Interest Increase1.53%HUMHumana$379.42+0.1%2.1659 of 5 stars2.21$291.35 -23.2%28Gap Down1.49%CYTKCytokinetics$70.153.7153 of 5 stars2.86$99.30 41.6%221.34%BIIBBiogen$200.053.5817 of 5 stars2.55$217.26 8.6%291.25%IDXXIDEXX Laboratories$560.883.4481 of 5 stars2.64$751.00 33.9%11Analyst Upgrade1.22%IMNMImmunome$18.383.6804 of 5 stars2.85$33.17 80.4%13Analyst Forecast1.20%CVSCVS Health$101.87-0.1%4.1014 of 5 stars2.85$100.68 -1.2%26Trending NewsAnalyst Downgrade1.13%REGNRegeneron Pharmaceuticals$612.144.8595 of 5 stars2.70$792.65 29.5%27Positive News This page (NASDAQ:TMED) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share T. Rowe Price Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMED Stock Alerts